Comments
Dr.Reddy’s Laboratories has announced the launch of its over-the-counter (OTC) olopatadine hydrochloride ophthalmic solution in the US market as approved by the US Food and Drug Administration (USFDA).
Solution USP 0.2% and 0.1% are indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander. USP 0.1% is also indicated for the temporary relief of red eyes.
Why Dr Reddy’s remains a good long-term bet despite recent rally
“This launch marks the entry of Dr.Reddy’s into the OTC eye care space, and is a testament to our deep capabilities in bringing store-brand equivalents of Rx-to-OTC switches to the US market,” says Marc Kikuchi, CEO, North America Generics, Dr.Reddy’s Laboratories. “We are very excited to extend our strategic collaboration with Gland Pharma to bring these products to the market. We thank the teams at Gland and Dr.Reddy’s, whose hard work and efforts have enabled the execution of this launch in such a short time frame.”
Dr Reddy’s to launch 25 products in US this fiscal
Dr.Reddy’s olopatadine hydrochloride ophthalmic solution USP 0.2% is available in a 2.5-ml bottle and USP 0.1% in 5-ml bottle size.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.